Clinical Trial Update: Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemotherapy in combination with autologous cell immunotherapy for recurrent and metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Autologous cell immunotherapy (autologous cell immunotherapy)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN